A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs

Journal of Infectious Diseases

Volumn 195, Issue 5, 2007, Pages 665-674

  Schul, Wouter ^a   Liu, Wei ^a   Xu, Hao Ying ^a   Flamand, Marie ^b   Vasudevan, Subhash G ^a  

^a NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEAZA 2' C METHYLADENOSINE; ADENOSINE DERIVATIVE; ANTIVIRUS AGENT; CASTANOSPERMINE 6 BUTYRATE; CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N NONYLDEOXYNOJIRIMYCIN; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 1; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DISEASE MODEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; VIREMIA; VIRUS REPLICATION;

1-DEOXYNOJIRIMYCIN; ANIMALS; ANTIVIRAL AGENTS; DENGUE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLIZINES; MICE; RIBAVIRIN; TIME FACTORS; TUBERCIDIN; VIREMIA; VIRUS REPLICATION;

EID: 33847042742     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/511310     Document Type: Article

References (41)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-3.
2. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
3. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-96.
4. Damonte EB, Pujol CA, Coto CE. Prospects for the therapy and prevention of dengue virus infections. Adv Virus Res 2004; 63:239-85.
5. Hotta H, Murakami I, Miyasaki K, Takeda Y, Shirane H, Hotta S. Inoculation of dengue virus into nude mice. J Gen Virol 1981; 52:71-6.
6. Raut CG, Deolankar RP, Kolhapure RM, Goverdhan MK. Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. Acta Virol 1996; 40:143-6.
7. Wu SJL, Hayes CG, Dubois DR, et al. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am J Trop Med Hyg 1995; 52:468-76.
8. Huang KJ, Li SY, Chen SC, et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000; 81:2177-82.
9. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol 2005; 79:13797-9.
10. Lin YL, Lia CL, Chen LK, et al. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 1998; 72:9729-37.
11. An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K. Development of a novel mouse model for dengue virus infection. Virology 1999; 263: 70-7.
12. An J, Zhou DS, Zhang JL, Morida H, Wang JL, Yasui K. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett 2004; 95:167-74.
13. Johnson AJ, Roehrig JT. New mouse model for dengue virus vaccine testing. J Virol 1999; 73:783-6.
14. Van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 1995; 69:4792-6.
15. McBride WJH, Vasudevan SG. Relationship of a dengue 2 isolate from Townsville, 1993, to international isolates. Comm Dis Intelligence 1995; 19:522-3.
16. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 1985; 22:250-4.
17. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-51.
18. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infection. J Clin Microbiol 2002; 40:376-81.
19. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002; 186:1165-8.
20. Suharti C, van Gorp EC, Setiati TE, et al. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost 2002; 87:42-6.
21. Suharti C, van Gorp ECM, Dolmans WMV, et al. Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 2003; 14:172-7.
22. Chen LC, Lei HY, Liu CC, et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006; 74:142-7.
23. Chakravarti A, Kumaria R. Circulation levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res 2006; 123:25-30.
24. Wu KL, Changchien CS, Kuo CH, et al. Early abdominal sonographic findings in patients with dengue fever. J Clin Ultrasound 2004; 32:386-8.
25. Venkata Sai PM, Dev B, Krishnan R. Role of ultrasound in dengue fever. Br J Radiol 2005; 78:416-8.
26. Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB. Systemic host inflammatory and coagulation response in the dengue virus primo-infection. Cytokine 2004; 27:173-9.
27. Pacsa AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS. Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2000; 28:151-5.
28. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161:6338-46.
29. Diamond MS, Zachariah M, Harris E. Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 2002; 304:211-21.
30. Leyssen P, Drosten C, Paning M, et al. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob Agents Chemother 2003; 47:777-82.
31. Olsen DB, Eldrup AB, Bartholomew L, et al. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Antimicrob Agents Chemother 2004; 48:3944-53.
32. Courageot MP, Frenkiel MP, Dos Santos CD, Deubel V, Desprès P. α-Glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol 2000; 74:564-72.
33. Whitby K, Pierson TC, Geiss B, et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol 2005; 79:8698-706.
34. Wu SF, Lee CJ, Liao CL, Dwek RA, Zitzmann N, Lin YL. Antiviral effects of an iminosugar derivative on flavivirus infections. J Virol 2002; 76:3596-604.
35. Kang MS. Uptake and metabolism of BuCast: a glycoprotein processing inhibitor and a potential anti-HIV drug. Glycobiology 1996; 6:209-16.
36. Whitby K, Taylor D, Patel D, Ahmed P, Tyms AS. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C. Antivir Chem Chemother 2004; 15:141-51.
37. Bridges CG, Ahmed SP, Kang MS, Nash RJ, Porter EA, Tyms AS. The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection. Glycobiology 1995; 5:249-53.
38. Fulton B, Markham A. Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996; 51:278-98.
39. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9.
40. Leon LR. Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 2002; 92:2648-55.
41. Smith RS. The cytokine theory of headache. Med Hypotheses 1992; 39:168-74.